Medtronic plc (BVMF:MDTC34)

Market Cap	693.27B
Revenue (ttm)	187.22B
Net Income (ttm)	25.66B
Shares Out	n/a
EPS (ttm)	19.88
PE Ratio	27.02
Forward PE	17.37
Dividend	5.85 (2.13%)
Ex-Dividend Date	Sep 25, 2025

Volume	11
Average Volume	13
Open	274.04
Previous Close	255.25
Day's Range	274.04 - 274.04
52-Week Range	227.76 - 274.04
Beta	0.74
RSI	66.62
Earnings Date	Nov 18, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: MDTC34

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD